Results 81 to 90 of about 18,346 (199)
Dysregulated endometrial receptivity is a well-established critical factor that contributes to recurrent implantation failure (RIF). Decidualization of stromal cells and differentiation of epithelial cells in the endometrium are crucial processes for ...
Xin Xu +9 more
doaj +1 more source
Menin-MLL1 complex cooperates with NF-Y to promote hepatocellular carcinoma survival
Summary: Chromatin regulators are frequently mutated or aberrantly expressed in hepatocellular carcinoma (HCC), suggesting that the dysregulation of chromatin is a key feature driving liver cancer.
Margarita Dzama-Karels +5 more
doaj +1 more source
Mario Menin. camicia nera futurista e primo battaglista del mondo
Mario Menin : camicia nera futurista e primo battaglista del mondo / (presentazione di Filippo Tommaso Marinetti e Luigi Scrivo). - Roma : Edizioni futuriste di poesia, stampa 1941 Dedica manoscritta dell\u27autore: A Bodrero Emilio / con ammirazione ...
Menin, Mario
core
Menin : a new actor in cell cycle ?
La NEM1 est un syndrome cancéreux affectant de nombreuses glandes endocrines, qui résulte d’une prédisposition génétique liée à des mutations du gène MEN1.
Ivo, Dina Isabel Antunes-
core
Menin enhances c-Myc-mediated transcription to promote cancer progression
Menin is a protein with context-dependent oncogenic or oncosuppressive roles; the oncogenic activity is mainly due to its function as a cofactor of the MLL1 histone methyltransferase complex.
Gongwei Wu +18 more
doaj +1 more source
Background Our previous studies found that Menin was highly expressed in gastric cancer (GC) and could promote GC progression. Tumor microenvironment (TME), including cancer-associated fibroblasts (CAFs) and their exosomes plays pivotal roles in GC.
Shan-Hu Wang +5 more
doaj +1 more source
Menin inhibitors for acute myeloid leukemia: latest updates from the 2023 ASH Annual Meeting
Recent developments in menin inhibitors for relapsed or refractory acute myeloid leukemia (AML) were highlighted at the 2023 ASH Annual Meeting. Notably, revumenib showed promising efficacy, achieving a 100% ORR when combined with decitabine/cedazuridine
Zhuo-Yu An, Xiao-Hui Zhang
doaj +1 more source
Prostate cancer (PC) progression is predominantly driven by androgen signaling, making androgen deprivation therapy (ADT) the standard treatment. However, the transition to castration-resistant prostate cancer (CRPC) significantly reduces ADT efficacy ...
Ipek Bulut +5 more
doaj +1 more source

